Graphene field effect transistor biosensors based on aptamer for amyloid-β detection by Salehirozveh, Mostafa et al.
\  
 
 
 
 
 
Salehirozveh, M., Dehghani, P., Zimmermann, M., Roy, V. A.L. and 
Heidari, H. (2020) Graphene field effect transistor biosensors based on 
aptamer for amyloid-β detection. IEEE Sensors Journal, (doi: 
10.1109/JSEN.2020.3000583) 
 
The material cannot be used for any other purpose without further 
permission of the publisher and is for private use only. 
 
There may be differences between this version and the published version. 
You are advised to consult the publisher’s version if you wish to cite from 
it.  
 
 
http://eprints.gla.ac.uk/217484/  
 
 
 
 
 
 
   Deposited on 09 June 2020 
 
 
 
 
 
Enlighten – Research publications by members of the University of       
           Glasgow 
http://eprints.gla.ac.uk  
 
1 
I. Introduction
VER 35 million people around the world suffered from
dementia in 2013 [1]. This number is estimated to double 
every 20 years reaching a value of 65.7 million in 2030, and of 
115.4 million in 2050 [2]. The most common cause of senile 
dementia is the Alzheimer's disease (AD), with currently over 
17 million patients worldwide [3]. The AD is often associated 
with deposition and aggregation of misfolded proteins such as 
amyloid-beta (Aβ) peptide in brain and forms plaques in the 
central neural system [4][5][6]. These aggregates can be 
observed in fibrillar and non-fibrillar forms. Aβ has two 
isoforms, Aβ40 and Aβ42, which have different rates in 
spontaneous self-association into oligomers and producing 
fibrils and plaques [7][8]. Since the generation of Aβ42 
aggregates is faster than Aβ40, it can be more neurotoxic [9]. 
AD diagnostic biosensors e.g. semiconductor-based field 
effect transistor (FET) can miniaturize current bulky and 
 
costly hospital-based tools such as Nuclear Magnetic 
Resonance [10][11], by enabling highly-sensitive technology 
to identify the specific proteins e.g. Aβ40 [12][13][14]. Two-
dimensional hexagonal network materials like graphene attract 
further attention in the field of diagnostic biosensors because 
of the high mobility of the carrier. For example, detection of 
proteins by electrochemical graphene biosensors were 
reported [15][16][17][18][19][20]. Research on Graphene 
field effect transistor (G-FET) which is based on graphene 
oxide or reduced graphene oxide has gradually increased in 
the detection of biomolecules like DNA [21], RNA [22], 
proteins [23], insulin [24] and bacteria [25][26]. In this 
context, to improve the performance of G-FET by increasing 
the mobility of the carrier in a graphene channel, a single layer 
of graphene is the best candidate [27].  
Recognition elements play a key role in a performance of 
biosensors. Aptamer as a receptor is a short single strand 
oligonucleotide of DNA or RNA that bind to specific targets. 
Aptamers offer several advantages like easy to design, cost-
efficient to produce, high affinity to targets, and more stable 
than antibodies [28]. During the past decade, several works of 
amyloid-binding aptamer have been reported. Ylera et al. was 
reported one of the first works on the design specific RNA 
aptamer with high affinity to Aβ40 and diagnosed amyloid- 
peptide as a risk factor in AD [29]. Multiple studies for 
developing the aptamer against Aβ have been reported based 
on SELEX and aptamer functionalization like fluorescently 
tagged anti-Aβ RNA aptamer [30][31][32][33].  
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For exploit r-GO FET in medical application, Debye length 
is the most considerations parameter, which defines as 
distance from mobile carriers in r-GO FET channel for 
screening the surplus charge in the solution. Hence, the 
charged molecules located out of this distance cannot be 
detected by the system. Accordingly, the reactions between 
targets and aptamer should occur within this sensing area. For 
example, a typical Debye length in 5-10 mM buffer at room 
temperature is about 5 nm [21]. The r-GO FET biosensors 
have been exploited for biological application by using DNA 
[34], enzyme [35] and antibody [17] as a receptor. In this 
work, we use aptamer (N2), which has a high affinity to bind 
to the amyloid protein [33]. 
We aim to develop a cost-efficient, sensitive and specific 
method for detecting Aβ42 by using a r-GO FET based on 
RNA aptamer, which was modified on the surface of its 
channel. Herein, graphene oxide synthesized by modified 
hummer method and confirmed with atomic force microscopy 
(AFM) and Fourier-transform infrared spectroscopy (FTIR). 
After self-assembly of GO on an aminated Si/SiO2 wafer, 
RNA aptamers were immobilized on r-GO channel by linkers 
and characterized by field emission scanning electron 
microscopy (FESEM) and AFM. Electrical measurements 
were used to investigate the sensitivity and selectivity of the 
fabricated device. 
II. Materials and methods
A. Materials
Si/SiO2 wafer was obtained from Singapore, graphite 
powder, 3-aminopropyltriethoxysilane (APTES), 
1,5diaminonaphthalene (DAN) and buffer phosphate saline 
(PBS), Glutaraldehyde, H2O2 (30%), ethanolamine, hydrazine 
monohydrate (85%) purchased from Sigma-Aldrich. sequence 
of aptamer probe designed by Takapoozist, the sequence of 
RNA probe is (5'-NH2-(CH2)4- UAGCGUAUGCCACUC 
UCCUGGGACCCCCCGCCGGAUGGCCA-CAUCC-3'. All 
chemical was of analytical grade and used without high purity 
nitrogen (99/99% purity) prior to the experiment. DI water 
was used throughout the work.   
Apparatus 
AFM images were obtained with VEECO (America) 
electron microscope. FESEM images were obtained with a 
Vega_Tescan electron microscopy. FTIR spectroscopic 
measurements were carried out with a Tensor 27 FT-IR 
spectrometer (Bruker). All electrochemical measurements 
were carried out with an Autolab PGSTAT 302N (Eco 
Chemie, Utrecht, the Netherlands; driven with NOVA 
software).   
Synthesis of GO 
GO nanosheets were synthesized by modified Hummer's 
method [36]. In order to reduce the size of nanosheets and 
achieve a single layer of GO, sonication was used. In the end, 
to prepare 1mg/ml concentration of GO and remove the large 
size of nanosheets, dispersion of GO in DI water was 
sonicated for 24 hours and centrifuged at 8,000 rpm for 45 
min.  AFM and FTIR were used to indicate the thickness and 
qualification of GO nanosheets.  
B. Fabrication of G-FET device
Fig. 1 shows the schematic steps of a surface modification 
of graphene FET. The Si/SiO2 substrate was cleaned by 
piranha solution (3H2SO4:1H2O2) for 20 min, then rinsed with 
DI water and toluene. The Si/SiO2 wafer was silanized with 
0.1% (v/v) APTES in anhydrous toluene for 4 hours [37]. 
After silanization, the remaining APTES molecules were 
washed with toluene to organize self-assembled monolayer of 
ATPES [38]. Then, the aminated Si/SiO2 wafer was immersed 
into GO dispersion for 6 h. After that, GO nanosheets were 
strongly bound to the aminated substrate. At last, the self-
assemble of GO nanosheets on the surface of the aminated 
substrate was reduced by hydrazine vapor for 18 h at 50 °C 
and heated at 220 °C for 12 h to produce r-GO.  
Fig. 2 illustrates the fabrication steps of the proposed r-GO 
FET. The Au source and drain (S/D) electrodes and Al2O3, 
which was capping the electrodes in order to barricade 
interaction of biomolecules to Au S/D were formed by thermal 
evaporating on r-GO layer using metal shadow mask on 
substrate. The width and length of r-GO channel which is 
located between the S/D electrodes are 40 μm and 3.2 mm 
respectively. Au electrodes were coated on the substrate by 
sputtering and using a metal mask to pattern and the PDMS 
layer was directly pasted on the Al2O3 capped S/D electrodes 
to remove the electrode-electrolyte leakage. Encapsulation of 
the electrode area by two Al2O3 and PDMS layers was 
important to keep level of the leakage current between gate 
and source electrodes undetectable during electrical 
measurements. At last, in order to isolate and seal the channel, 
acrylic fixture with the length of 4 mm, the height of 100 μm 
and width of 200 μm was used and top gate was located at top 
of the fixture that is in contact with the analyte which is 
illustrated in Fig. 3a. Here, for transport the Aβ solution, two 
syringes were designed at top of the fixture as input and output 
pump to circulate the sample solution through the channel, as 
shown in Fig. 3.  
Fig. 1.  Schematic formation of a GO on amine-SAM on Si/SiO2 
wafer. Silanization of Si/SiO2 wafer by APTES after cleaning the 
surface by piranha solution. Monolayer of silane creates on the 
surface of substrate. Self-assembly of GO-nanosheets on amine 
SAM substrate. 
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C. Immobilization of Aptamer
RNA aptamer oligonucleotide of Alzheimer with 5' amino 
modification was synthesized by Takapoozist. The base 
sequence: (5'-UAGCGUAUGCCACUCUCCUGGGA 
CCCCCCGCCGGAUGGCCA-CAUCC-3'). For preparing 
100 μM concentration, the aptamer was dissolved in 100 mM 
phosphate-buffered saline (PBS) (pH 7.4). The aptamer was 
immobilized on r-GO to work as a receptor for Aβ42 by using 
1,5diaminonaphthalene (DAN) and glutaraldehyde linkers. 
The Polydimethylsiloxane (PDMS) well was filled with 100 
μM DAN in 40 μL methanol for 1 h. Then it was rinsed with 
methanol and DI water. The DAN component was bound to r-
GO by π-π stacking between a network of r-GO and a pyrenyl 
group. 20 μL of 2% glutaraldehyde in PBS (pH 7) was used 
for conjugating to DAN for 2 h and then washed with PBS. 
The well was incubated with 100 nM of Alzheimer aptamer in 
PBS in pH 7 for 15 h at room temperature. After the 
incubation, the substrate was washed with PBS at pH 7. The 
transfer curve of r-GO FET was observed after immobilization 
(Fig. 8).  
After immobilization of aptamer and introducing Aβ42, 
AFM and FESEM were used to confirm the processes.  
D. Blocking the surface of r-GO for specific detection
After immobilization of aptamers on the surface of r-GO, 
bare areas that were not covered with receptors were blocked 
by immersing the substrate in 10 μg/ml bovine serum albumin 
(BSA) solution for 10 min at 4 °C in order to prevent non-
specific attachment of targets with the bare surface.  
E. Aptamer sensing characteristic
Electrical measurements were performed by observing the 
changes in drain current while different concentration of Aβ42 
in PBS (10mM Na2HPO4 and 10mM NaH2PO4) from 1ng/ml 
to 1pg/ml were injected. Voltage was applied to the reference 
electrode.  
Aβ42 was prepared with 20 mM NaOH to a final 
concentration of 0.5 mM. The solution was then sonicated for 
Fig. 2.  Schematic of r-GO FET device fabrication and detection of Aβ-
Aptamer complex. Formation of Au S/D electrode, covering the 
electrode by Al2O3 and using PDMS layers to isolate the device. 
Functionalization of channel by DAN and glutaraldehyde and 
immobilization of Aptamer to linkers on surface of r-GO channel and 
blocking the surface by BSA for non-specific binding. 
Fig. 4.   (a) Typical AFM image of GO, and (b) height profile of single to 
bi-layer of GO nanosheet. 
(a)
(b)
Fig. 3. (a) Schematic and (b) optical images of acrylic fixture. 
(a)
(b)
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1 min and kept at room temperature for 5 min to completely 
dissolved the sample. This was followed by centrifuging at 
13,000 rpm for 20 min to remove any aggregates that might 
have formed in the solution. The supernatant was used as the 
stock solution. Prior to each experiment, aliquots of the 0.5 
mM stock solution were diluted with 10 mM phosphate buffer 
(pH 7.4) to 25 μM [39].  
III. RESULTS AND DISCUSSION
A. Characterization of GO
Nanosheets of GO were visualized by AFM. Fig. 4a depicts 
the typical image of GO and Fig. 4b shows the thickness of 
GO sheets. The thickness of GO sheets were in a rage of 1.3–
1.7 nm, which indicates the presence of hydroxyl, epoxy and 
carboxyl groups on surface and side of GO sheets and the 
existence of single to bi-layer of GO [40][41][42][43].  
FTIR analysis of GO (Fig.5) shows the following 
characteristic peaks of functional groups. Stretching peak for 
C-O-C (~1060 cm-1), vibration peaks for C-O (~1185 cm-1)
and C=C (~1618 cm-1), bending vibration peaks for O-H
(~1370 cm-1) and stretching vibration for C=O (~1720 cm-1),
and O-H ( 3200-3500 cm-1), which is about residual water
between GO sheets and hydroxyl and carboxyl groups of GO
nanosheets. The results demonstrates the large amounts of
oxygen-containing groups exposed on the surface of GO
[44][45][46].
B. Characterization of the modified r-GO channel
First, we functionalized the r-GO by DAN and 
glutaraldehyde as linkers. Then topography from the surface 
of the r-GO channel was analyzed by AFM after 
immobilization of Alzheimer aptamer and adding Aβ42. As 
shown in Fig.6, AFM results demonstrate immobilization of 
aptamer on the surface of the modified r-GO channel with a 
room-mean-squared (RMS) roughness of 1.7 nm. After adding 
Aβ42 the RMS was 4.68 nm. The small spots in the 
illustration demonstrate the high density of aptamer-binding to 
the r-GO channel.  
In order to confirm the immobilization of aptamer on the 
surface of r-GO channel, FESEM was used. The results from 
aptamer immobilization indicate densely distributed 
Alzheimer aptamer on the r-GO channel (Fig. 7a). Fig. 7b and 
7c show the middle of the r-GO channel and the edge of 
electrode respectively. As shown in figure 7c, the upper and 
a) 
a) 
b) 
Fig. 6.  AFM images of channel modified with aptamer and Aβ42. (a) 
Topography from the surface after immobilization of aptamer and (b) 
introducing Aβ42. 
Fig. 5.   FTIR spectra of GO. 
Fig. 7.  FESEM images of showing immobilization of aptamer on 
modified r-GO. (a) Aptamers were densely assembled on surface of 
channel. (b) Image from show the middle of the r-GO channel and (c) 
from the electrode’s edge that the upper part of image is Au electrode 
and the downside is a r-GO channel. 
(b) 
a) b) 
c)
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lighter part of the image is Au electrode and the other dark 
side is an r-GO channel. 
C. Protein detection
The effect of Alzheimer aptamer immobilization on the 
surface of r-GO channel was investigated by electrical 
measurements. Fig. 8 shows the transfer curve of the drain 
current (ID) versus top gate voltage (VTGS) of bare r-GO FET 
(black line) in comparison to r-GO FET (red line) with 
immobilized aptamer at a drain voltage (VD) of 10 mV in PBS. 
As shown in Fig. 8, ID increased after immobilization. This 
results from an increase in density of negative charge due to 
binding of aptamer on the r-GO channel. This indicates the 
successful immobilization of Alzheimer aptamer on the 
surface of the r-GO channel. It should be noted that the same 
slope of ID- VTGS curves express no defects were presented on 
the surface of r-GO by immobilization. 
The transfer curves of aptamer-modified r-GO FET in 
response to the different concentrations of Aβ42 ranging from 
1ng/ml to 1pg/ml at a drain voltage (VD) of 70 mV in PBS 
depicted in Fig. 9. The positive shift of the transfer curve is 
due to the negative charge of Aβ42 (pI=5.5), which induces p-
doping to aptamer-modified r-GO FET. On the other hand, 
interaction between aptamer and Aβ42 within the Debye 
Length, caused an increase in current because of the change in 
electrical composition of electrolyte after adding the Aβ42. 
Fig. 10 shows the calibration curve representing the 
relationship between the drain current on the one hand and the 
concentration of Aβ42 on the other hand. The upper detection 
limit was reduced from 1ng/ml to 1 pg/ml. It should be 
mentioned that, because of the formation of layer of Aβ42 
fibril during 4h and near-full coverage of the channel surface 
due to the hydrogen bonding occurred between protofibril and 
fibril [47][48][49], the decreasing in ion permeation through 
this protein layer was occurred that leaded to reduce in gate 
capacitance [48]. Also, this formation of the Aβ42 layer, 
chemical structure of r-GO that consists of unreduced, 
covalently bonded oxygen groups, and absorbed BSA on r-
GO, caused small reduction in mobility of carriers in a r-GO 
channel [48][50][51]. Therefore, the measurement was 
performed at VD of 70 mV to achieve the highest sensitivity 
and limit of detection in these ranges of concentrations.  
To investigate the specificity of the aptamer-modified r-GO 
FET, different proteins were added. Fig. 11 shows the time 
course of normalized ID for aptamer-modified r-GO FET. 100 
pg/ml BSA, IgE and Aβ42 were added to the aptamer-
modified channel for 4h. ID slightly increased after adding 
BSA. On the other hand, ID decreased slightly after adding 
IgE. Fig. 11 shows a significant increase in ID after adding 
Aβ42. The discrepancy in the drain current change can be 
a) b) c) 
Fig. 8.  Transfer curve, before and after modifying r-GO with aptamer. 
The black demonstrates the drain current (ID) versus top gate voltage 
(VTGS) of bare r-GO FET and the red line belongs to r-GO FET after 
immobilization of aptamer. 
Fig. 9.  Detection of Aβ42 aggregation by aptamer-modified r-GO 
FET. The change of transfer curve of aptamer-modified r-GO FET 
were recorded for 4h by introducing different concentration of Aβ42 
solution at pH 7.4. The gradual aggregation of the negatively charged 
Aβ42 (pI=5.5) induced a p-doping to aptamer-modified r-GO FET. 
Fig. 10.  Calibration curve of drain current as a function of different 
concentration of Aβ42. 
Fig. 11.  The course time of normalized ID for r-GO FET with aptamer-
modified channel. 100 pg/ml of BSA, IgE and Aβ42 in buffer 
phosphate at pH 7.4 were injected on to the aptamer-modified 
channel for 4h.  
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explained by the difference in the isoelectric point of these 
proteins. The isoelectric points of BSA and Aβ42 are 5.3 and 
5.5, respectively, which indicate that both proteins are 
negatively charged in phosphate-buffer solution at pH 7.4. The 
isoelectric point of IgE is 6.5~9.5. Since the ID decreased after 
adding the IgE molecules. Therefore, the results indicate that 
the Aptamer-modified r-GO FET was successfully responded 
to the Aβ42 specifically. All in all, this bio-FET can detect 
extremely small quantities of Aβ42 with high specificity.  
IV. Conclusion
We could develop a (1) cost efficient method for detecting 
(2) small concentrations of Aβ ranging from 1ng/ml to 1pg/ml
with (3) high specificity. Currently, diagnosis of Alzheimer´s
disease is supported by measurement of decreased CSF-
concentrations of Aβ42 in CSF and increased concentrations
of h-TAU and p-TAU in CSF by methods like ELISA. The
sensitivity of the commercial ELISA is in the range of pM,
while our device had a wide dynamic range from 1ng/ml to
1pg/ml [52][53][54]. Several research groups tried to also
measure Aß42 in plasma samples, which would be a faster and
easier way with also more acceptance from the patient´s point
of view including immunoassay and xMAP [53][55]. Another
prerequisite is a high specificity of such a method since there
are a lot of plasma proteins leading to possible false positive
results when also resulting into a detection signal or even to
false negative results when preventing the binding of amyloid-
proteins. We could detect very small concentrations of Aβ42
in a range of 1ng/ml to 1pg/ml with our reduced graphene
oxide field effect transistor-method. Adding BSA or IgG did
not lead to a significant change in drain current, too, thus
enabling potential measurements in plasma samples with a
high specificity.
As future work, we cover the limitation of this study and 
link it with clinical and imaging data. All in all, our new 
method might help to improve early diagnosis of Aβ 
pathology as a very important requirement for future disease-
modifying therapies or other medical drugs since this enables 
an early begin of therapy.  
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